1. Scrivani SJ, Keith DA, Kaban LB. Temporomandibular Disorders. N Engl J Med. 2008;359(25):2693-705.
2.Bianchi J, de Oliveira Ruellas AC, Goncalves JR, et al. Osteoarthritis of the Temporomandibular Joint can be diagnosed earlier using biomarkers and machine learning. Sci Rep. 2020;10(1):8012.
3. Ruparelia PB, Shah DS, Ruparelia K, et al. Bilateral TMJ involvement in rheumatoid arthritis. Case Rep Dent. 2014;262430.
4. de Souza RF, Lovato da Silva CH, Nasser M, et al. Interventions for the management of temporomandibular joint osteoarthritis. COCHRANE DB SYST REV. 2012; 4:CD007261.
5. Wang XD, Zhang JN, Gan YH, et al. Current understanding of pathogenesis and treatment of TMJ osteoarthritis. J Dent Res. 2015;94: 666-73.
6. Ke J, Long X, Liu Y, et al. Role of NF-κB, in TNF-α induced COX-2 expression in synovial fibroblasts from human TMJ. J Dent Res. 2007;86:363-67.
7. Wang XD, Kou XX, Mao JJ, et al. Sustained Inflammation Induces Degeneration of the Temporomandibular Joint. J Dent Res. 2012;91(5):499-505.
8. Xu L, Guo H, Li C, et al. A time-dependent degeneration manner of condyle in rat CFA-induced inflamed TMJ. Am J Transl Res. 2016;8(2):556-67.
9. Embree M, Ono M, Kilts T, et al. Role of subchondral bone during early-stage experimental TMJ osteoarthritis. J Dent Res. 2011;90:1331-8.
10. Ogura N, Satoh K, Akutsu M, et al. MCP-1 production in temporomandibular joint inflammation. J Dent Res. 2010;8910(10):1117-22.
11. Barbin T, Groppo FC, Toledo FC, et al. The effect of omega-3 in temporomandibular joint synovial tissues of rats with induced arthritis: pilot study. Int J Oral Maxillofac Surg. 2020;http://doi: 10.1016/j.ijom.2020.01.012.
12. den Sousa LM, Dos Santos Alves JM, da Silva Martins C, et al. Immunoexpression of canonical Wnt and NF‑κB signaling pathways in the temporomandibular joint of arthritic rats. Inflammation Research. 2019;6810(10).
13. Fassio A, Adami G, Gatti D, et al. Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators. Int Immunopharmacol. 2019;67:487-9.
14. Gertel S, Mahagna H, Karmon G, et al. Tofacitinib attenuates arthritis manifestations and reduces the pathogenic CD4 T cells in adjuvant arthritis rat. Clin Immunol. 2017;184:77-81.
15. Kopp S, Alstergren P, Ernestam S, et al. Reduction of Temporomandibular Joint Pain after Treatment with a Combination of Methotrexate and Infliximab Is Associated with Changes in Synovial Fluid and Plasma Cytokines in Rheumatoid Arthritis. Cells Tissues Organs. 2005;180:22-30.
16. Gunson MJ Arnett GW, Milam SB. Patho- physiology and pharmacologic control of osseous mandibular condylar resorption. J Oral Maxillofac Surg. 2012;70:1918–34.
17. Taylor PC & Feldmann M. Anti-TNF biologic agents: still the therapy of choice for rheu-matoid arthritis. Nat Rev Rheumatol. 2009;5:578-82.
18. Rhodes B, Fürnrohr BG, Vyse TJ. C-reactive protein in rheumatology: biology and genetics. Nat Rev Rheumatol. 2011;7:282-9.
19. Luan YY & Yao YM. The Clinical Significance and Potential Role of C-Reactive Protein in Chronic Inflammatory and Neurodegenerative Diseases. Front Immunol. 2018;9:1302.
20. Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375(9709):132-40.
21. Lin JZ, Liu Y, Ma JD, et al. Reduced skeletal muscle independently predicts 1-year aggravated joint destruction in patients with rheumatoid arthritis. Ther Adv Musculoskel Dis. 2020;12: 1-15.
22. Hanada M, Takahashi M, Furuhashi H, et al. Elevated erythrocyte sedimentation rate and high-sensitivity C-reactive protein in osteoarthritis of the knee: relationship with clinical findings and radiographic severity. Ann Clin Biochem. 2016;53(5):548e53.
23. Fredriksson L, Alstergren P, Kopp S. Tumor Necrosis Factor-α in Temporomandibular Joint Synovial Fluid Predicts Treatment Effects on Pain by Intra-Articular Glucocorticoid Treatment. Mediators Inflamm. 2006;6(6): 1-7.
24. Voog U, Alstergren P, Eliasson S, et al. Inflammatory mediators and radiographic changes in temporomandibular joints of patients with rheumatoid arthritis. Acta Odontol Scand. 2003;61(1):57-64.
25. Liang C, Li J, Lu C, et al. HIF1α inhibition facilitates Leflunomide-AHR-CRP signaling to attenuate bone erosion in CRPaberrant rheumatoid arthritis. Nat Commun. 2019;10(1): 1-13.
26. Kim KW, Kim BM, Moon HW, et al. Role of C-reactive protein in osteoclastogenesis in rheumatoid arthritis. Arthritis Research & Therapy. 2015;17:41.
27. Jiang S, Xia D, Samols D. Expression of rabbit C-reactive protein in transgenic mice inhibits development of antigen-induced arthritis. Scand J Rheumatol. 2006;35:351-5.
28. Jones NR, Pegues MA, McCrory MA, et al. Collagen-Induced Arthritis Is Exacerbated in C-Reactive Protein–Deficient Mice. ARTHRITIS & RHEUMATISM. 2011;63(9):2641-50.
29. Yang M, Qiu S, He Y, et al. Genetic ablation of C-reactive protein gene confers resistance to obesity and insulin resistance in rats. Diabetologia. 2021;64(5):1169-83.
30. Fuentes R, Veuthey C, Arias A, et al. Injection in temporomandibular joint of rats. Description of technical protocol. POL J VET SCI. 2017;20(2):207–11.
31. He Y., Xu H., Xiang Z., et al. YAP regulates periodontal ligament cell differentiation into myofibroblast interacted with RhoA/ROCK pathway. J Cell Physiol. 2019;234(4):5086-96.
32. Fang Z, Lv J, Wang J, et al. C-Reactive Protein Promotes the Activation of Fibroblast-Like Synoviocytes From Patients With Rheumatoid Arthritis. Front Immunol. 2020;11:958.
33. Jia ZK, Li HY, Liang YL, et al. Monomeric C-reactive Protein Binds and neutralizes receptor activator of NF-κB ligand-induced Osteoclast Differentiation. Front Immuno. 2018;9:234.
34. Braig D, Nero TL, Koch HG, et al. Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites. Nat Commun. 2017;8:14188.
35. Rhodes B, Merriman ME, Harrison A, et al. A genetic association study of serum acute-phase C‑reactive protein levels in rheumatoid arthritis: implications for clinical interpretation. PLoS Med. 2010;7: e1000341.
36. Kozijn AE, Tartjiono MT, Ravipati S, et al. Human C-reactive protein aggravates osteoarthritis development in mice on a high-fat diet. Osteoarthritis Cartilage. 2019;271(1):118-28.
37. Devaraj S, Singh U, Jialal I. Human C-reactive protein and the metabolic syndrome. Curr.Opin.Lipidol. 2009;20(3):182e9.
38. Kou XX, Li CS, He DQ, et al. Estradiol Promotes M1-like Macrophage activation through cadherin-11 to aggravate temporomandibular joint inflammation in rats. J IMMUNOL. 2015;194(6):1-10.
39. Zhang W, Cai Y, Xu W, et al. C-reactive protein functions as a negative regulator of macrophage activation induced by apoptotic DNA. Protein Cell. 2011;2(8): 672-9.
40. Hunter MM, Wang A, Parhar KS, et al. In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice. Gastroenterology. 2010;138:1395-1405.
41. Rigoglou S & Papavassiliou AG. The NF-κB signaling pathway in osteoarthritis. Int. J. Biochem. Cell Biol. 2013;45:2580-84.
42. He Y, Zhou M, Jian Z, et al. C-Reactive Protein Knock Out Attenuate Temporomandibular Joint Inflammation in Rats.